These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19956772)

  • 1. Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.
    Han L; Wierenga AT; Rozenveld-Geugien M; van de Lande K; Vellenga E; Schuringa JJ
    PLoS One; 2009 Nov; 4(11):e7989. PubMed ID: 19956772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
    Schepers H; van Gosliga D; Wierenga AT; Eggen BJ; Schuringa JJ; Vellenga E
    Blood; 2007 Oct; 110(8):2880-8. PubMed ID: 17630355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
    Sun H; Tsai Y; Nowak I; Liesveld J; Chen Y
    Stem Cell Res; 2012 Sep; 9(2):77-86. PubMed ID: 22683680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF activates signal transduction from EPO receptor on human cord blood CD34+/CD45+ cells.
    Iguchi T; Sogo S; Hisha H; Taketani S; Adachi Y; Miyazaki R; Ogata H; Masuda S; Sasaki R; Ito M; Fukuhara S; Ikehara S
    Stem Cells; 1999; 17(2):82-91. PubMed ID: 10195568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines.
    Urashima M; Hoshi Y; Akiyama M; Kamijo M; Kato Y; Akatsuka J; Maekawa K; Matsuzaki M; Ohnishi J; Kaihara C
    Acta Paediatr Jpn; 1995 Apr; 37(2):160-5. PubMed ID: 7540792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
    Denning-Kendall P; Singha S; Bradley B; Hows J
    Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
    Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
    Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
    Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
    Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
    Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
    Schuringa JJ; Chung KY; Morrone G; Moore MA
    J Exp Med; 2004 Sep; 200(5):623-35. PubMed ID: 15353555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
    De Bruyn C; Delforge A; Martiat P; Bron D
    Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells.
    Mayani H; Dragowska W; Lansdorp PM
    Blood; 1993 Jun; 81(12):3252-8. PubMed ID: 7685200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT5 signaling in normal and pathologic hematopoiesis.
    Bunting KD
    Front Biosci; 2007 May; 12():2807-20. PubMed ID: 17485261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.